Cleared Traditional

K872125 - BARD ABG 100 INTRAVASCULAR OXYGEN MONIT...

K872125 is an FDA 510(k) clearance for BARD ABG 100 INTRAVASCULAR OXYGEN MONIT..., manufactured by C.R. Bard, Inc.. The device is a Class 2 Anesthesiology device with product code CCE cleared through the Traditional 510(k) pathway after a 192-day FDA review.

K872125 · C.R. Bard, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1987
Decision
192d
Days
Class 2
Risk

K872125 is an FDA 510(k) clearance for the BARD ABG 100 INTRAVASCULAR OXYGEN MONITOR. SYSTEM. Classified as Analyzer, Gas, Oxygen, Partial Pressure, Blood-phase, Indwelling (product code CCE), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Tewksbury, US). The FDA issued a Cleared decision on December 11, 1987 after a review of 192 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1200 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all C.R. Bard, Inc. devices

FDA 510(k) Submission Details - K872125

510(k) Number K872125 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 1987
Decision Date December 11, 1987
Days to Decision 192 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d slower than avg
Panel avg: 140d · This submission: 192d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCE Device Classification - Class 2, Special Controls

Product Code CCE Analyzer, Gas, Oxygen, Partial Pressure, Blood-phase, Indwelling
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCE Analyzer, Gas, Oxygen, Partial Pressure, Blood-phase, Indwelling

All 14
Devices cleared under the same product code (CCE) and FDA review panel - the closest regulatory comparables to K872125.
BARD ABG 100 INTRAVASCULAR OXYGEN MONITOR SYSTEM
K884063 · C.R. Bard, Inc. · Dec 1988
UMBILICAL ARTERY OXYGEN SENSOR
K875225 · Ohmeda Medical · Mar 1988
UMBILICAL ARTERY OXYGEN PROBE MODEL UAP-100
K872896 · American Bentley · Feb 1988
OXYGEN MONITOR NO. OM-100, OXYGEN PROBE NO. OP-100
K860106 · American Bentley · Feb 1986
OXYGEN MONITOR OM-100 & OXYGEN PROBE OP-100
K853786 · American Bentley · Oct 1985
VENOUS OXYGEN PROBE
K811071 · G.D. Searle and Co. · May 1981